IRADIMED CORPORATION

NasdaqCM:IRMD Stock Report

Market Cap: US$549.2m

IRADIMED Balance Sheet Health

Financial Health criteria checks 6/6

IRADIMED has a total shareholder equity of $71.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $92.2M and $20.7M respectively. IRADIMED's EBIT is $20.0M making its interest coverage ratio -10.7. It has cash and short-term investments of $49.8M.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ratio-10.7x
CashUS$49.76m
EquityUS$71.42m
Total liabilitiesUS$20.74m
Total assetsUS$92.16m

Recent financial health updates

No updates

Recent updates

If EPS Growth Is Important To You, IRadimed (NASDAQ:IRMD) Presents An Opportunity

Feb 23
If EPS Growth Is Important To You, IRadimed (NASDAQ:IRMD) Presents An Opportunity

Getting In Cheap On IRadimed Corporation (NASDAQ:IRMD) Is Unlikely

Feb 07
Getting In Cheap On IRadimed Corporation (NASDAQ:IRMD) Is Unlikely

Should You Investigate IRadimed Corporation (NASDAQ:IRMD) At US$45.06?

Nov 06
Should You Investigate IRadimed Corporation (NASDAQ:IRMD) At US$45.06?

Calculating The Intrinsic Value Of IRadimed Corporation (NASDAQ:IRMD)

Oct 13
Calculating The Intrinsic Value Of IRadimed Corporation (NASDAQ:IRMD)

At US$41.26, Is It Time To Put IRadimed Corporation (NASDAQ:IRMD) On Your Watch List?

Feb 05
At US$41.26, Is It Time To Put IRadimed Corporation (NASDAQ:IRMD) On Your Watch List?

Iradimed withdraws FDA filing for new infusion pump; prelim Q3 revenue rises 13% Y/Y

Oct 10

IRadimed: Record Revenue Could Translate To Share Price Appreciation

Aug 23

Here's Why We Think IRadimed (NASDAQ:IRMD) Is Well Worth Watching

Aug 17
Here's Why We Think IRadimed (NASDAQ:IRMD) Is Well Worth Watching

iRadimed Non-GAAP EPS of $0.26 beats by $0.02, revenue of $12.7M beats by $0.06M

Jul 29

IRadimed: Reduce Equity Beta With Upside Capture

Jul 18

IRadimed (NASDAQ:IRMD) Might Be Having Difficulty Using Its Capital Effectively

Jul 13
IRadimed (NASDAQ:IRMD) Might Be Having Difficulty Using Its Capital Effectively

At US$48.60, Is IRadimed Corporation (NASDAQ:IRMD) Worth Looking At Closely?

Feb 05
At US$48.60, Is IRadimed Corporation (NASDAQ:IRMD) Worth Looking At Closely?

Here's What's Concerning About IRadimed's (NASDAQ:IRMD) Returns On Capital

Jan 12
Here's What's Concerning About IRadimed's (NASDAQ:IRMD) Returns On Capital

Returns On Capital At IRadimed (NASDAQ:IRMD) Paint A Concerning Picture

Jul 13
Returns On Capital At IRadimed (NASDAQ:IRMD) Paint A Concerning Picture

iRadimed EPS beats by $0.04, beats on revenue

Apr 30

iRadimed EPS misses by $0.02, beats on revenue

Feb 04

If You Had Bought IRadimed (NASDAQ:IRMD) Stock Five Years Ago, You Could Pocket A 70% Gain Today

Jan 31
If You Had Bought IRadimed (NASDAQ:IRMD) Stock Five Years Ago, You Could Pocket A 70% Gain Today

Financial Position Analysis

Short Term Liabilities: IRMD's short term assets ($76.0M) exceed its short term liabilities ($16.3M).

Long Term Liabilities: IRMD's short term assets ($76.0M) exceed its long term liabilities ($4.4M).


Debt to Equity History and Analysis

Debt Level: IRMD is debt free.

Reducing Debt: IRMD had no debt 5 years ago.

Debt Coverage: IRMD has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: IRMD has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.